Medical professional liability insurers reported total direct written premium of $6.9 billion in 2023, the highest level in 20 years, per our latest report.

🔗bit.ly/3xOTyFz

#insurance #healthcare #milliman

For #healthcare stakeholders reporting percent-of-Medicare results, the scope and payment amounts should be clearly defined and appropriate for the comparison goals.

🔗 bit.ly/3xWo7JO

#Medicare #insurance #milliman

The industry is dealing with significant changes as a result of high inflation and the complexities of new regulations. We present 5 case studies to show techniques that helped clients improve their processes.

🔗 us.milliman.com/en/insight/ope…

#insurance #milliman

New guidance in #Malaysia acknowledges a number of significant developments and challenges in managing Medical and #HealthInsurance /Takaful business.

👉 bit.ly/3vU8fXr

#milliman #healthcare

Learn 5 key takeaways from our analysis of chronic condition special needs plans, a type of Medicare Advantage offering.

👩‍⚕️ bit.ly/4cXcG4u

#MedicareAdvantage #healthinsurance #healthcare #milliman

REACH ACOs need to incorporate into financial projections another likely retrospective trend adjustment from the Center for #Medicare and #Medicaid Innovation.

🔗 bit.ly/3VZSeK2

#healthinsurance

Gain insight into the complexities surrounding the intersection of #Medicare and #Medicaid , and explore opportunities to better serve dual-eligible beneficiaries.

Part 1️⃣ bit.ly/3W7VMdc

#healthcare #milliman

Gain a closer look at accountable care organizations (ACOs) under the Medicare Shared Savings Program, identifying some key trends and patterns associated with financial success.

bit.ly/3J43NZh

#healthcare #milliman #medicare

In our third performance driver study of the #Medicare Shared Savings Program, we identify regional efficiency as an important characteristic for accountable care organization (ACO) total savings.

👉 bit.ly/3VPO5bt

#insuarnce #healthcare #milliman

Learn 5 key takeaways regarding combined benefits in #MedicareAdvantage , highlighting some common package groupings and non-uniform benefits.

🔗 bit.ly/43K0sYA

#healthcare #milliman

With the growth of value-based insurance design in the Medicare Advantage market, we outline the landscape for this year and offer insights for 2025 and beyond.

bit.ly/4ahtjGs

#medicareadvantage #milliman

How might CMS’s proposed change to agent compensation alter the landscape for #MedicareAdvantage and prescription drug programs?

bit.ly/3TGZOGT

#healthinsurance #milliman

With the growth of value-based insurance design in the Medicare Advantage market, we outline the landscape for this year and offer insights for 2025 and beyond.

bit.ly/3PIUQYT

#medicare #medicare advantage #healthinsurance #insurance #milliman

Year after year legislation is filed to eliminate or modify vital health plan tools. A Milliman, Inc. report found the elimination of prior auth would result in an additional $5.5 billion in premium costs annually for the commercial market. Learn more: rb.gy/vkxu92

The Primary Care First model by CMS is set to redefine our healthcare system. In our recent article, we delve into what this means for patient care and the future of healthcare. Join the conversation. #CMS #PrimaryCareFirst #HealthcareFuture

milliman.com/en/insight/cms…

What do accountable care organizations (ACOs) need to know about the soon-to-be-released #shadowbundles data from CMSGov?

Get your answers here: bit.ly/3ODl2nq

#Medicare #CMS #Healthcare #Milliman #ACOs

GLP-1 agonists, like Ozempic and Wegovy, reached $4.0 billion in gross #Medicaid spend through Q3 2023. Learn about the growth in usage and Medicaid spending for these drugs, used for type 2 diabetes and weight management. bit.ly/3tWeeKt

#Pharmaceuticals #Milliman

To help you prepare for Solvency II reporting in the year ahead, we designed a timeline for Solvency II reporting deadlines in 2024 and changes in the reporting framework relative to 2023.

Zoom into the whole infographic here: bit.ly/48n7m7N

#solvencyII #insurance

We just launched The #Milliman Qualified Entity Reporting Dashboard. This research tool gives payers, providers, and researchers data points about #healthcare systems & social determinants of health in the US.

Try out the interactive dashboard: bit.ly/3Nix3h9

We just launched The #Milliman Qualified Entity Reporting Dashboard. This research tool gives payers, providers, and researchers data points about #healthcare systems & social determinants of health in the US.

Try out the interactive dashboard: milliman.com/qualifiedentity